News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering extended genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists from The Institute of Cancer Research, London.
Simple blood test could lead to smarter, kinder treatments for childhood cancers
Institute of Cancer Research scientists have developed a simple blood test that will help them better understand children’s cancers - and pave the way for new targeted and less toxic treatments.
-16-9.jpg?sfvrsn=b9495114_2 "Glioblastoma cells (Dr Chris Jones/the ICR) 16:9")
Newly identified therapeutic target may lead to effective treatments for the most common and dangerous form of brain cancer
Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma, a common type of adult brain tumour, rely on a specific enzyme for survival and that inhibiting this enzyme leads to the death of the cells.
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escape
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions.
Scientists show that the immune system indirectly influences the genes that drive cancer
Researchers have uncovered new details about the complex relationship between the immune system and cancer.
Breast cancer risk model provides reassuring data for those with family history of disease after short-term HRT use
Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk model published in the British Journal of General Practice.
Neoadjuvant radiotherapy provides unique insights into breast tumour immune microenvironment
A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours.
Scientists create new way to predict bowel cancer risk in people with inflammatory bowel disease
Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer.
Uncovering the secrets of the secretome – underexplored cells near tumours may hold the answer to drug resistance
A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment.
New method could improve the standard care of people with advanced cancer that has spread to the bones
Scientists have successfully used a form of artificial intelligence (AI) to develop a new imaging approach that makes it easier for radiologists to assess the extent of bone disease in people with advanced prostate cancer or multiple myeloma.
The future of ovarian cancer: innovation, treatment and hope
Ovarian cancer is often diagnosed late, making it difficult to treat. But innovative research at The Institute of Cancer Research, London, is changing how we think about managing this complex and hard-to-treat disease. Robbie Lockyer speaks to molecular pharmacology expert and medical oncologist Professor Udai Banerji to find out more about therapeutic research strategies.
